Caterina AM La Porta
Caterina AM La Porta
Email verificata su unimi.it - Home page
TitoloCitata daAnno
Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential
E Monzani, F Facchetti, E Galmozzi, E Corsini, A Benetti, C Cavazzin, ...
European journal of cancer 43 (5), 935-946, 2007
5852007
Glioblastoma‐derived tumorospheres identify a population of tumor stem‐like cells with angiogenic potential and enhanced multidrug resistance phenotype
A Salmaggi, A Boiardi, M Gelati, A Russo, C Calatozzolo, E Ciusani, ...
Glia 54 (8), 850-860, 2006
3032006
Molecular mechanisms triggered by mercury
GP Guzzi, CAM La Porta
Toxicology 244 (1), 1-12, 2008
2732008
Modulation of pro-and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors
F Facchetti, S Previdi, M Ballarini, S Minucci, P Perego, CAM La Porta
Apoptosis 9 (5), 573-582, 2004
1212004
AQP1 is not only a water channel: it contributes to cell migration through Lin7/beta-catenin
E Monzani, R Bazzotti, C Perego, CAM La Porta
PLoS One 4 (7), e6167, 2009
1002009
Drug resistance in melanoma: new perspectives
CAM La Porta
Current medicinal chemistry 14 (4), 387-391, 2007
972007
Increased plasma levels of soluble CD40, together with the decrease of TGFβ1, as possible differential markers of Alzheimer disease
A Mocali, S Cedrola, N Della Malva, M Bontempelli, VAM Mitidieri, ...
Experimental gerontology 39 (10), 1555-1561, 2004
772004
Cancer stem cells and therapeutic perspectives
E Galmozzi, F Facchetti, CAM Porta
Current medicinal chemistry 13 (6), 603-607, 2006
642006
Unique expression and localization of aquaporin‐4 and aquaporin‐9 in murine and human neural stem cells and in their glial progeny
C Cavazzin, D Ferrari, F Facchetti, A Russignan, AL Vescovi, ...
Glia 53 (2), 167-181, 2006
642006
Mechanism of drug sensitivity and resistance in melanoma.
CAP La
Current cancer drug targets 9 (3), 391-397, 2009
612009
CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells
R Taghizadeh, M Noh, YH Huh, E Ciusani, L Sigalotti, M Maio, B Arosio, ...
PloS one 5 (12), e15183, 2010
592010
Cancer stem cells: lessons from melanoma
C La Porta
Stem Cell Reviews and Reports 5 (1), 61-65, 2009
552009
Decrease of TGF-β1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer's disease
B De Servi, CAM La Porta, M Bontempelli, R Comolli
Experimental gerontology 37 (6), 813-821, 2002
552002
Pertussis toxin-sensitive G-protein mediates galanin's inhibition of scopolamine-evoked acetylcholine release in vivo and carbachol-stimulated phosphoinositide turnover in rat…
S Consolo, R Bertorelli, P Girotti, C La Porta, T Bartfai, M Parenti, ...
Neuroscience letters 126 (1), 29-32, 1991
531991
The water channels, new druggable targets to combat cancer cell survival, invasiveness and metastasis
E Monzani, AA Shtil, CAM La Porta
Current drug targets 8 (10), 1132-1137, 2007
502007
Changes in protein kinase C alpha, delta and in nuclear beta isoform expression in tumour and lung metastatic nodules induced by diethylnitrosamine in the rat.
CA La Porta, L Tessitore, R Comolli
Carcinogenesis 18 (4), 715-719, 1997
501997
Senescent cells in growing tumors: population dynamics and cancer stem cells
CAM La Porta, S Zapperi, JP Sethna
PLoS computational biology 8 (1), e1002316, 2012
472012
Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers
S Zapperi, CAM La Porta
Scientific reports 2, 441, 2012
452012
Do cancer cells undergo phenotypic switching? The case for imperfect cancer stem cell markers
S Zapperi, CAM La Porta
Scientific reports 2, 441, 2012
452012
Thoughts about cancer stem cells in solid tumors
CAM La Porta
World journal of stem cells 4 (3), 17, 2012
412012
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20